肝硬化急性肾损伤的死亡率:跨不同临床场景逾500万患者的系统评价与荟萃分析
该系统评价与荟萃分析纳入59项比较肝硬化伴与不伴急性肾损伤(AKI)患者的研究,共包括1,153,193例AKI患者和4,630,814例无AKI患者,检索截至2023年10月。结果显示AKI与住院、30天、90天及1年死亡率升高相关,ICU患者短期死亡率达76%(95%CI 73%-79%),慢加急性肝衰竭(ACLF)患者达54%(95%CI 33%-73%)。AKI分期、发生时机及诊断标准均影响预后。
要点
- 肝硬化合并AKI患者短期、中期及长期死亡率均显著高于无AKI患者。
- ICU的AKI患者短期死亡率达76%(95%CI 73%-79%),ACLF合并AKI患者达54%(95%CI 33%-73%)。
- AKI分期越高死亡率越高,社区获得与医院获得性AKI的死亡模式不同,诊断标准选择亦影响短期死亡风险关联。
核心结论
- AKI显著影响肝硬化患者预后,尤其是ICU和/或ACLF患者,预后还受AKI分期、发生时机及诊断标准影响。
研究设计与样本
- 系统检索多个数据库至2023年10月,采用广义线性混合模型及随机效应模型进行荟萃分析。
- 共纳入59项比较肝硬化伴与不伴AKI患者的研究,包括1,153,193例AKI患者和4,630,814例无AKI患者。
主要发现
- AKI与住院、30天、90天及1年死亡率升高相关,住院和门诊患者均如此。
- ICU的AKI患者短期死亡率达76%(95%CI 73%-79%),ACLF合并AKI患者达54%(95%CI 33%-73%)。
- AKI分期越高死亡率越高;社区获得性与医院获得性AKI的死亡模式不同;诊断标准选择可能影响与短期死亡风险的关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute kidney injury (AKI) represents a commonly seen condition in the natural course of cirrhosis associated with unfavourable outcomes. AIMS: To evaluate and compare the pooled mortality rates of patients with cirrhosis, with versus without AKI, across different clinical settings and diagnostic criteria. METHODS: A systematic search of several databases was performed up to Oct 2023. Meta-analysis was performed using a generalised linear mixed model with a random effects model for all calculations. RESULTS: A total of 59 studies comparing patients with cirrhosis, with and without AKI, were included in the meta-analysis, encompassing 1,153,193 individuals with AKI and 4,630,814 without AKI. AKI development predisposed to significantly higher short (in-hospital and 30-days)-, intermediate (90-days)- and long (1-year)-term mortality rates in both inpatients and outpatients. Remarkably, patients with AKI admitted to intensive care unit (ICU) or diagnosed with acute-on-chronic liver failure (ACLF) experienced the higher short-term mortality rates, reaching 76% [95% confidence interval (CI): 73%-79%] and 54% (95%CI: 33%-73%), respectively. AKI staging correlated with mortality risk, with higher stages indicating higher mortality rates, while the timing of AKI development, whether community-acquired or hospital-acquired, plays a crucial role in patient prognosis, with distinct mortality patterns observed in each group. The selection of diagnostic criteria for AKI may also impact its association with the short-term mortality risk. CONCLUSIONS: AKI substantially affects the prognosis of patients with cirrhosis, especially those in ICU and/or with ACLF. Prognosis is also greatly influenced by the AKI stage, timing of onset and diagnostic criteria.
引用
- Lekakis V, Wong F, Gkoufa A, et al. Mortality of Acute Kidney Injury in Cirrhosis: A Systematic Review and Meta-Analysis of Over 5 Million Patients Across Different Clinical Settings. Aliment Pharmacol Ther. 2024. PMID: 39641300. doi:10.1111/apt.18426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。